  See all
 |
Articles: Drug Trials |
Prior Articles
Positive Phase IIb Results for GSK1838262 (XP13512) Reported for Neuropathic Pain Associated with Post-Herpetic Neuralgia
XenoPort, 09/18/09
Head-to-head trial demonstrates Viramune®’s similar efficacy and more favourable effect on lipid profile compared to atazanavir/ritonavir
Boehringer Ingelheim, 09/17/09
Free full text
18 month Follow-up Data on Phase III Study of Pixantrone in Late Stage Relapsed or Refractory, Aggressive Non-Hodgkins Lymphoma Continues to Demonstrate Significant Improvement in Complete Remission and Progression Free Survival Over Standard Chemotherap
Cell Therapeutics, 09/17/09
Free full text
Fondaparinux and the Management of Heparin-Induced Thrombocytopenia
Annals of Pharmacotherapy, 09/16/09 New analysis supports tiotropium as initial maintenance therapy for COPD For medical media, outside the US only
Boehringer Ingelheim, 09/16/09
Free full text
Cytokinetics Presents Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the 2009 Heart Failure Society of America Annual Meeting
Cytokinetics, 09/16/09
Free full text
Novartis investigational bronchodilator QAB149 improves lung function and reduces breathlessness compared to tiotropium in patients with COPD
Novartis, 09/16/09
Free full text
Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses of Rifaximin in the Treatment of Non–Constipation Irritable Bowel Syndrome in Two Phase 3 Trials
Salix Pharmaceuticals, 09/15/09
Free full text
Randomized Controlled Trial of Proactive Web-Based Alcohol Screening and Brief Intervention for University Students
Archives of Internal Medicine, 09/15/09 ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus, Its Investigational mTOR Inhibitor, in Metastatic Sarcomas
ARIAD Pharmaceuticals, 09/15/09
Free full text
NIAID News Release: Statement: Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults
National Institute of Allergy and Infectious Disease - News, 09/14/09 Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
PLoS Medicine, 09/14/09
Free full text
Mistrial Declared in First Federal FOSAMAX Trial
Merck & Co., 09/14/09
Free full text
Genzyme’s Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data
Genzyme, 09/14/09
Free full text
Pivotal Data Demonstrating Efficacy of Darusentan in Treating Resistant Hypertension Published in The Lancet
Gilead, 09/14/09
Free full text
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
Sanofi-aventis, 09/14/09
Free full text
REFINE (Reducing Falls in In-Patient Elderly) - a randomised controlled trial
Trials, 09/11/09
Free full text
Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results
Mpex Pharmaceuticals, 09/11/09 Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
PLoS Medicine, 09/10/09
Free full text
Wean Earlier and Automatically with New technology (the WEAN study): a protocol of a multicentre, pilot randomized controlled trial
Trials, 09/09/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
